Television and print ads continually tout the impression that pharmaceutical companies have the consumers’ best interests at heart. Yet, many of these same drug makers are being fined for engaging in deceptive marketing practices and failing to warn consumers about known risks. A Case In Point: Sanofi Fined $52.8M for Engaging in Deceptive Practices French pharmaceutical giant, Sanofi SA, has been fined $52.8 million (the equivalent of over 40 million euros) for attempting to reduce the sales of generic competitors… Read More
The Driscoll Firm Legal Blog Archive
A new study shows that nearly 25% of all vaginal bulge surgeries to treat pelvic organ prolapse (POP) fail and that symptoms generally return within seven years. The study’s results may complicate matters for the U.S. Food & Drug Administration, which is trying to determine whether vaginal bulge surgery or surgery using transvaginal mesh implants is safer and more effective for women. The FDA has asked more than 30 TVM manufacturers to conduct further studies. JAMA Study Reviews Data on… Read More
